Project Grant H8G48617

This $199,295 National Science Foundation project grant funded the development of a comparative online simulation tool for COVID-19 vaccine allocation strategies. Funded under the Biological Sciences program (CFDA 47.074), the Fred Hutchinson Cancer Research Center will create a mathematical model of SARS-CoV-2 transmission incorporating multiple vaccines, viral variants, and demographic factors. This model will then be used to develop a free, open-source, online comparative tool allowing up...

This federal Project Grant award of $220,000.00 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop and test a novel intervention to improve routine vaccination of hospitalized children. The project, titled "PRESUMPTIVELY INITIATING VACCINES AND OPTIMIZING TALK FOR INPATIENTS (PIVOT-IN)", will involve two key components: 1) a standardized screening approach to...

The National Science Foundation (NSF) awarded a $448,823 Project Grant under its Social, Behavioral, and Economic Sciences program (CFDA 47.075) to the Trustees of Boston University. This two-year grant, running from September 1, 2023 to August 31, 2025, aims to assess the effectiveness of various health communication tactics employed by federal, state, and local agencies to encourage vaccine uptake. The project will build a database of vaccine messaging from public health agencies, evaluate the...

This federal Cooperative Agreement award for $5,358,220.00, provided by the National Center for Immunization and Respiratory Diseases (part of the Centers for Disease Control and Prevention), supports the Hawaii Department of Health's efforts to increase vaccination rates in the state. The award, made on January 17, 2025 under the Public Health Emergency Response: Cooperative Agreement for Emergency Response (CFDA 93.354) program, will fund the creation and maintenance of a workgroup within...

The National Science Foundation (NSF) awarded a $997,689 Cooperative Agreement under its NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Omnicyte LLC, a minority-owned small business in Branford, CT. The funding supports the design and production of a next-generation COVID-19 vaccine that addresses weaknesses of current vaccines, such as reduced booster effectiveness, short-lived efficacy, and side effects. The project aims to develop a vaccine candidate with improved...

This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 Minority Health and Health Disparities Research) provides $2,065,719 to New York University to conduct a community-based behavioral intervention study to increase COVID-19 and influenza vaccination rates among African American/Black and Latino populations. The study aims to identify the most cost-effective combination of intervention components, including nurse-led shared decision...

This federal Cooperative Agreement award, with a total funding amount of $3,047,740.00, was provided by the National Center for Immunization and Respiratory Diseases, a division of the Centers for Disease Control and Prevention (CDC). The award supports the "Partnerships to Enhance Immunization Information Systems" project under the CDC's Federal Grant Program CFDA 93.185 "Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills...

This Cooperative Agreement award in the amount of $454,754.00 was provided by the National Center for Chronic Disease Prevention and Health Promotion, part of the Centers for Disease Control and Prevention (CDC), under the Immunization Cooperative Agreements program (CFDA 93.268). The award will support the Rhode Island Department of Health (RIDOH) in establishing and maintaining preventive health service programs to immunize individuals against vaccine-preventable diseases, including measles,...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements program (CFDA 93.268) provides $3,048,538 to the Pennsylvania Department of Health (PADOH) to enhance the state's capacity to detect, respond, prevent, and control emerging infectious disease threats. The 5-year award, effective August 1, 2024, will strengthen PADOH's epidemiologic and laboratory capacities, improve public health informatics, and enhance...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323) will provide $1,050,000.00 over a five-year period starting September 30, 2024 to the University of Arizona to enhance vaccine uptake in border and rural regions. The project aims to use community-based participatory research to develop innovative approaches to increase vaccination rates across the...